Brief: Kuros To Receive $4 Million Milestone Payment From Checkmate Pharmaceuticals

Kuros Biosciences AG

17/05/2021 06:03

May 17 (Reuters) - KUROS BIOSCIENCES AG  KURN.S :
    * TO RECEIVE $4 MILLION MILESTONE PAYMENT FROM CHECKMATE
PHARMACEUTICALS
    * KUROS STANDS TO RECEIVE UP TO $49 MILLION ADDITIONAL
MILESTONES
PLUS ROYALTIES ON SALES
    * PAYMENT RELATED TO DOSING OF FIRST PATIENT IN A PHASE 2
TRIAL OF
VIDUTOLIMOD (CMP-001) IN COMBINATION WITH NIVOLUMAB FOR
TREATMENT OF PATIENTS WITH ANTI-PD-1 REFRACTORY ADVANCED
MELANOMA, UNDER A LICENSE AGREEMENT BETWEEN COMPANIES

Source text for Eikon:  ID:nEQ7DjJbna 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))